WASHINGTON, February 16, 2024 – The ERISA Industry Committee (ERIC) submitted comments today to the Washington House Health Care & Wellness Committee urging it to pass SB 5821, which would make permanent the current state rule allowing a patient and provider to establish a relationship using audio-only telehealth technology.
Level Archives:
ERIC Retirement & Compensation Highlights: PTE Process Final Regulation; Long-Term, Part-Time Comment Letter Filed; and More!
ERIC Health Care Highlights: Ed & Workforce Hearing; Site Neutral Payment Advocacy; and More!
ERIC Retirement & Compensation Policy Highlights: Programming Announcements; Oregon Paid Leave Comments Submitted; and More!
The ERISA Industry Committee Urges Oregon Employment Department to Amend Rules Implementing Paid Leave Oregon Program
WASHINGTON, November 30, 2023 – In comments submitted today to the Oregon Employment Department, The ERISA Industry Committee (ERIC) recommended key provisions of proposed permanent regulations contained in “Paid Leave Oregon – Batch 9 – Appeals, Assistance Grants, Benefits, Confidentiality, Equivalent Plans, and Self-employment” be amended or developed further to prevent unnecessary compliance complications and better facilitate coordination of overlapping benefits.
ERIC Alert: Member Company Feedback Requested on Draft Oregon Paid Leave Regulatory Comments
ERIC Retirement & Compensation Policy Highlights: PBGC Annual Report; Comment Period for Fiduciary Proposal; and More!
ERIC Alert: State Paid Leave Regulatory Updates and Request for Member Feedback; State Paid Leave Strategy Calls
ERIC Win: New York Department of Financial Services Withdraws Proposed PBM Network Regulations
The ERISA Industry Committee Asks Ohio Legislature to Recognize Value of Proven Biosimilar Products
WASHINGTON, November 1, 2023 – The ERISA Industry Committee (ERIC) today submitted a comment letter to the Ohio House of Representatives Insurance Committee urging the panel to amend House Bill 291 to include access to all biosimilar products, a necessary step to ensure that the bill will promote competition, and drive lower drug costs for Ohioans.